MARICAR TACBAD: Open Payments
NPI 1225765480 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,002 in 34 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $393 · 2025 $1,002
Food & beverage: $903Education: $99
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 8 | $245 |
| AstraZeneca Pharmaceuticals LP | 10 | $181 |
| PFIZER INC. | 1 | $118 |
| SEAGEN INC. | 1 | $99 |
| GlaxoSmithKline, LLC. | 1 | $86 |
| Eisai Inc. | 3 | $71 |
| pharmaand GmbH | 2 | $46 |
| ABBVIE INC. | 2 | $41 |
| Genmab U.S., Inc. | 1 | $30 |
| Aadi Bioscience, Inc. | 1 | $21 |
Products named: KEYTRUDA, LYNPARZA, ELREXFIO, Lenvima, ENHERTU, Rubraca, ELAHERE, Tivdak.
Industry payments across NM — which companies pay providers there.
